🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,589 results for “Pharma” Clear

  1. Venlafaxine 25 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  2. Venlafaxine Hydrochloride

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    3 trials

  3. Virus-specific T-cell Immunity for the Treatment of Some Resistant Viral Infections After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

    Istituto Gentili S.r.l.

    Patients who have received an allogeneic haematopoietic stem cell transplant and who have developed post-transplant viral reactivation (CMV, Adenovirus, EBV) resistant to pharmacological therapies.

    phase 1 other active

    1 trial

  4. Voclosporin

    Aurinia Pharmaceuticals

    Volunteers

    phase 1 small molecule completed

    1 trial

  5. Volanesorsen

    IONIS PHARMACEUTICALS INC

    Abnormalities, Cardiovascular

    phase 1 small molecule completed

    1 trial

  6. Vonoprazan

    Phathom Pharmaceuticals

    Gastroesophageal Reflux Disease

    phase 1 small molecule completed

    1 trial

  7. Vonoprazan

    Phathom Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials

  8. Vonoprazan

    Phathom Pharmaceuticals

    Healthy Participants

    phase 1 small molecule terminated

    2 trials

  9. Vonoprazan

    Phathom Pharmaceuticals

    Gastroesophageal Reflux

    phase 1 small molecule completed

    1 trial

  10. Vonoprazan ODT-1 or ODT-2 without Water

    Phathom Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  11. Vyxeos

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukemia

    phase 1 small molecule active

    1 trial

  12. Vyxeos 44 MG / 100 MG Liposome Injection

    Jazz Pharmaceuticals Ireland Limited

    Relapsed Pediatric AML

    phase 1 small molecule active

    1 trial

  13. X4P-001

    X4 Pharmaceuticals, Inc

    Melanoma

    phase 1 small molecule completed

    1 trial

  14. X4P-001

    X4 Pharmaceuticals, Inc

    Healthy

    phase 1 small molecule terminated

    1 trial

  15. XEN901

    Xenon Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  16. XM17

    Teva Pharma GmbH

    Bioequivalence

    phase 1 small molecule completed

    1 trial

  17. XPF-001

    Xenon Pharmaceuticals

    Healthy Human Volunteers

    phase 1 small molecule completed

    1 trial

  18. XPF-008

    Xenon Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  19. XPF-008

    Xenon Pharmaceuticals

    Healthy Male Volunteers

    phase 1 small molecule completed

    1 trial

  20. XTL 6865

    XTL BIOPHARMACEUTICALS LTD

    Hepatitis C

    phase 1 small molecule active

    1 trial

  21. XTL-2125

    XTL BIOPHARMACEUTICALS LTD

    Chronic Hepatitis C Virus Infection

    phase 1 small molecule terminated

    1 trial

  22. XeriSol glucagon

    Xeris Biopharma Holdings

    Type1diabetes

    phase 1 small molecule completed

    1 trial

  23. Y150

    Wuhan YZY Biopharma Co.,

    Relapsed or Refractory Multiple Myeloma

    phase 1 small molecule completed

    1 trial

  24. YN001

    Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

    Cardiovascular Diseases

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources